Investor Relations International

Investor Relations International (IRI) is a strategic investor relations and corporate communications firm that provides specialized services to micro-cap and small-cap companies, with a significant practice area focused on the life sciences and healthcare sectors. The firm assists biotechnology and medical device companies in building visibility within the investment community through targeted outreach to institutional investors, analysts, and retail brokers. IRI's service suite includes financial media relations, strategic advisory, and crisis management designed to help emerging growth companies navigate capital markets. Headquartered in Newport Beach, California, the firm acts as a key intermediary for innovative companies seeking to bridge the gap between corporate milestones and market awareness. While not a drug developer itself, IRI is a prominent service provider that has represented numerous public biotech entities over its two-decade history.